Clinical Trial Update: Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses [Phase 4]

View source ↗

Summary

A Phase 4 study reports results comparing outcomes for treatment-resistant depression patients treated with VNS therapy at different dose levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Vagus nerve stimulation (VNS) system

Snippet

Sponsor: Cyberonics, Inc. | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2013-02-25